Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance

Dec. 29, 2021

Icaritin derivatives as potential DEPTOR inhibitors against multiple myeloma

Dec. 28, 2021

Blocking phosphoglycerate dehydrogenase can reduce lymphoma progression

Dec. 28, 2021

BeiGene presents new IAP protein inhibitors

Dec. 28, 2021

Shanghai Antengene discovers GTPase KRAS inhibitors

Dec. 28, 2021

ScinnoHub Pharmaceutical divulges inhibitors of RET, Src and BTK

Dec. 28, 2021

New mutant EGFR inhibitors patented by Jiangsu Simcere Pharmaceutical R&D

Dec. 27, 2021

Wigen Biomedicine Technology discovers EGFR kinase inhibitors

Dec. 27, 2021

Nanjing Ruijie Pharma identifies tyrosine-protein kinase SYK inhibitors

Dec. 27, 2021

New Ex20Ins mutant EGFR inhibitors decribed by Inventisbio Shanghai

Dec. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...